CANCER PREVENTION PHARMACEUTICALS INC has a total of 16 patent applications. Its first patent ever was published in 2011. It filed its patents most often in Canada, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals are KIANI IRAJ E, CONCIT PHARMA APS and YEO OH YOUNG.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 2 | |
#2 | United States | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Chile | 1 | |
#7 | China | 1 | |
#8 | Colombia | 1 | |
#9 | EPO (European Patent Office) | 1 | |
#10 | Hong Kong | 1 | |
#11 | Israel | 1 | |
#12 | Republic of Korea | 1 | |
#13 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Ducassou Jean | 11 |
#2 | Shannon Patrick | 10 |
#3 | Bravo Gonzalez Roberto Carlos | 9 |
#4 | Gerner Eugene | 2 |
#5 | Roberto Carlos Bravo Gonzalez | 2 |
#6 | Cohen Alfred | 2 |
#7 | Patrick Shannon | 2 |
#8 | Boytim Michelle | 2 |
#9 | Mclaren Christine E | 1 |
#10 | Zell Jason | 1 |
Publication | Filing date | Title |
---|---|---|
US2020360329A1 | Methods for treating familial adenomatous polyposis | |
WO2017075576A1 | Eflornithine and sulindac, fixed dose combination formulation | |
CN108366982A | Eflornithine and sulindac, the combination preparation of fixed dosage |